Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) the leading RNAi therapeutics company, announced today the appointment of Peter Kellogg to its Board of Directors. Mr. Kellogg is an accomplished...
Alnylam Pharma (NASDAQ:ALNY) reported Q4 EPS of ($1.39), $0.46 better than the analyst estimate of ($1.85). Revenue for the quarter came in at $335.04 million versus the consensus estimate...
Investing.com - Alnylam (NASDAQ: ALNY) reported fourth quarter EPS of $-1.39, $0.46 better than the analyst estimate of $-1.85. Revenue for the quarter came in at $335.04M versus the...
By Davit Kirakosyan EF Hutton initiated coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy rating and a price target of $304.00. The company announced that the U.S. Food and Drug...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s...
Alnylam Pharma (ALNY) reported Q3 EPS of ($1.58), $0.15 better than the analyst estimate of ($1.73). Revenue for the quarter came in at $264.3 million versus the consensus estimate of...
Alnylam Pharma (NASDAQ:ALNY) reported Q2 EPS of ($2.03), $0.42 worse than the analyst estimate of ($1.61). Revenue for the quarter came in at $224.82 million versus the consensus estimate of...
Alnylam Pharma (NASDAQ:ALNY) reported Q1 EPS of ($1.49), $0.35 better than the analyst estimate of ($1.84). Revenue for the quarter came in at $213.26 million versus the consensus estimate...
By Sam Boughedda Investing.com — In a research note Monday, Oppenheimer analyst Leland Gershell told investors that Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) shares appear oversold...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Oil & Gas, Industrials and Financials sectors propelled shares higher while losses in the Utilities,...
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Basic Materials, Oil & Gas and Industrials sectors propelled shares higher while losses in the Healthcare,...
* Weekly jobless claims fall to 249,000 vs. est. 257,000 * Wal-Mart (NYSE:WMT) top drag on S&P, Dow * Pfizer falls after deal to sell infusion therapy business * Indexes down: Dow...
* Weekly jobless claims fall to 249,000 vs. est. 257,000 * Wal-Mart (NYSE:WMT) drops after issuing flat profit forecast for next year * Tesla falls after Goldman Sachs (NYSE:GS)...
* Futures down: Dow 28 pts, S&P 4 pts, Nasdaq 7.75 pts By Yashaswini Swamynathan Oct 6 (Reuters) - U.S. stock index futures were lower on Thursday as improving economic data and...
* U.S. crude prices up more than 2 pct * Ulta Salon up after qtrly sales beat estimates * Indexes up: Dow 1.25 pct, S&P 1.43 pct, Nasdaq 1.42 pct(Updates to early open) By Abhiram...
* Crude prices up more than 2 pct * All 30 Dow components rise * Symantec up after stock upgrade * Indexes up: Dow 0.89 pct, S&P 0.93 pct, Nasdaq 0.97 pct(Updates to open) By Abhiram...
* U.S. crude up more than 2 pct * Symantec up after stock upgrade * Futures up: Dow 138 pts, S&P 17.75 pts, Nasdaq 45.75 pts(Adds details, comment, updates prices) By Abhiram...
* Futures up: Dow 142 pts, S&P 18.75 pts, Nasdaq 47.75 ptsBy Abhiram Nandakumar March 11 (Reuters) - U.S. stock index futures rose on Friday as oil prices held on to gains, a day after...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
